Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
CG Oncology, Inc. - Common stock
(NQ:
CGON
)
36.88
+0.20 (+0.55%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CG Oncology, Inc. - Common stock
CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 30, 2024
From
CG Oncology Inc.
Via
GlobeNewswire
CGON Stock Earnings: CG Oncology Beats EPS for Q2 2024
August 08, 2024
CGON stock results show that CG Oncology beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
CG Oncology Reports Second Quarter 2024 Financial Results and Provides Business Updates
August 08, 2024
From
CG Oncology Inc.
Via
GlobeNewswire
A Closer Look at 9 Analyst Recommendations For CG Oncology
June 28, 2024
Via
Benzinga
Decoding 10 Analyst Evaluations For CG Oncology
May 14, 2024
Via
Benzinga
CG Oncology Initiates Expanded Access Program for Cretostimogene Grenadenorepvec
June 18, 2024
- First Patient Dosed in Expanded Access Program and Enrollment Ongoing -
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive NMIBC
June 06, 2024
From
CG Oncology Inc.
Via
GlobeNewswire
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
June 03, 2024
Via
Benzinga
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 03, 2024
Via
Benzinga
CG Oncology to Present Positive Final Results from Phase 2 CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive High-Risk NMIBC at ASCO 2024 Annual Meeting
May 24, 2024
54% complete response (CR) rate at 24-month landmark and meets primary endpoint of the phase 2 study
From
CG Oncology Inc.
Via
GlobeNewswire
CGON Stock Earnings: CG Oncology Misses EPS for Q1 2024
May 09, 2024
CGON stock results show that CG Oncology missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
CG Oncology Reports First Quarter 2024 Financial Results and Provides Business Updates
May 09, 2024
From
CG Oncology Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
May 03, 2024
Via
Benzinga
Cretostimogene Monotherapy Demonstrated 75.2% Complete Response Rate in High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
May 03, 2024
From
CG Oncology Inc.
Via
GlobeNewswire
Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday
May 03, 2024
Via
Benzinga
CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024
April 26, 2024
Company to host virtual investor event on Friday, May 3, 2024, at 4:30pm EDT following presentation of results from the Phase 3 BOND-003 trial at the 2024 AUA Annual Meeting
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024
April 24, 2024
- Final results of CORE-001 Phase 2 trial of cretostimogene in combination with pembrolizumab for the treatment of BCG-unresponsive NMIBC -
From
CG Oncology Inc.
Via
GlobeNewswire
IPO Stocks: Will Reddit Unplug The Bulging U.S. IPO Pipeline?
March 28, 2024
A bulging pipeline of IPOs are registered, ready to go, and closely watching Reddit's performance. Here are the concerns.
Via
Investor's Business Daily
Topics
Initial Public Offering
Exposures
Securities Market
CG Oncology to Present Results on Cretostimogene at the AUA 2024 Annual Meeting
March 28, 2024
- New 12-month data from the Phase 3 BOND-003 trial to be featured in an oral presentation in the Paradigm-shifting, Practice-changing Clinical Trials in Urology plenary session -
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology Announces First Patient Dosed in PIVOT-006 Phase 3 Clinical Trial of Cretostimogene in Intermediate-risk Non-Muscle Invasive Bladder Cancer
February 27, 2024
From
CG Oncology Inc.
Via
GlobeNewswire
Everyone's Talking About These 2 Biotech IPO Stocks, But Are They Buys?
February 25, 2024
The market's excited for these stocks, but there's no rush to buy them.
Via
The Motley Fool
Topics
Initial Public Offering
Exposures
Securities Market
3 attractive stocks that insiders are buying
February 12, 2024
The insiders are buying these attractive stocks. With a bank, a tech, a penny stock, a dividend payer, and a pharmaceutical winner, there is something for all.
Via
MarketBeat
CymaBay Therapeutics, ContextLogic, Snap And Other Big Stocks Moving Higher On Monday
February 12, 2024
U.S. stocks were mixed, with the Nasdaq Composite trading almost flat on Monday. Shares of CymaBay Therapeutics, Inc. (NASDAQ: CBAY) rose sharply in today’s pre-market trading.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
CG Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
January 30, 2024
From
CG Oncology, Inc.
Via
Business Wire
KKR-Backed BrightSpring Prices Below Expectations, Then Opens Lower
January 28, 2024
Health-care services provider BrightSpring, which is backed by private equity firm KKR, priced its initial public offering at $13, below a marketed range of $15 to $18 per share, before opening on...
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
KLA Reports Q2 Results, Joins Visa, Western Digital And Other Big Stocks Moving Lower In Friday's Pre-Market Session
January 26, 2024
U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.